Skip to main navigation Skip to search Skip to main content

Nalmefene in the treatment of internet pornography addiction – A case report and review of literature.

Research output: Contribution to journal › Article › peer-review

Abstract

The mu-opioid antagonist nalmefene (18 mg per day) was administered in the treatment of a heterosexual male with internet pornography addiction. The patient had no other co-addictions or psychiatric comorbidities, allowing a direct measurement for the effectiveness of nalmefene on internet pornography addiction. Over a period of 72 weeks and an assessment frequency between 1 and 18 weeks, self-monitoring assessments of craving and pornography consumption were collected on different craving and obsessive-compulsive scales. Results indicate that nalmefene impressively decreased addictive symptoms. Importantly, the patient-induced discontinuation of nalmefene led to an immediate increase of craving scores and addictive behavior, which dropped again after restarting the medication. The patient has been in complete remission of symptoms for over a year under our supervision, and for further 2 years after that according to his account. Therefore, nalmefene seems to be a useful adjunction for patients with internet pornography addiction.
Original languageEnglish
Pages (from-to)348-351
Number of pages4
JournalJournal of Addiction Medicine
Volume14
Issue number4
DOIs
Publication statusPublished - 01 Jul 2020

Fields of science

  • 303 Health Sciences
  • 304 Medical Biotechnology
  • 305 Other Human Medicine, Health Sciences
  • 301 Medical-Theoretical Sciences, Pharmacy
  • 302 Clinical Medicine

Cite this